Duration of Hot Flushes After Starting Amlodipine
Hot flushes (flushing) from amlodipine typically persist as long as the medication is continued, though they may diminish in intensity over the first 7-8 days as steady-state plasma levels are reached. This side effect is dose-dependent and represents an ongoing pharmacologic effect rather than a transient reaction 1.
Understanding the Mechanism and Timeline
Flushing from amlodipine results from peripheral vasodilation—the drug's primary mechanism of action. The FDA labeling clearly indicates that flushing is a recognized side effect that is more common with the higher 10 mg dose 2.
Pharmacokinetic Considerations
The persistence of flushing relates directly to amlodipine's pharmacokinetic profile:
- Terminal elimination half-life: 30-50 hours 1
- Steady-state reached: 7-8 days of consecutive dosing 1
- Duration of action: >24 hours after a single dose 2
This means the vasodilatory effect—and therefore flushing—is continuous during treatment. The symptom doesn't "resolve" after a specific timeframe; rather, it may become less bothersome as patients acclimate or if the body develops some tolerance to the vasodilatory sensation.
Clinical Management Strategy
If flushing is problematic:
- Wait through the first 7-8 days: Some patients report subjective improvement once steady-state is achieved, though the pharmacologic effect persists
- Consider dose reduction: If on 10 mg, reducing to 5 mg often decreases flushing intensity while maintaining blood pressure control 2
- Evaluate if discontinuation is necessary: If flushing significantly impacts quality of life and persists beyond 2-4 weeks without improvement, consider switching to an alternative antihypertensive class
Important Caveats
Do not confuse flushing with other vasodilatory side effects like peripheral edema, which also occurs with amlodipine but represents a different mechanism (increased capillary hydrostatic pressure). Both are dose-dependent but may have different time courses for patient tolerance.
The evidence does not support that flushing will spontaneously resolve while continuing the medication at the same dose—it is an expected pharmacologic consequence of calcium channel blockade and peripheral vasodilation that persists throughout treatment.